Therapeutics

Preliminary analysis of data from an ongoing investigator-initiated, single-center Phase 1 study supported by BioNTech and Genentech and conducted at Memorial Sloan Kettering Cancer Center, New York, United States. Autogene […]

Research by Oregon State University has uncovered a potential new therapy for pancreatic cancer, whose survival rate is among the lowest of all malignancies.

When you’re facing a pancreatic cancer diagnosis, humor may be tough to come by. Instead, feelings of grief, sadness, depression and anxiety become so all-consuming that getting a chuckle from […]

Results from an ongoing phase 2b GRECO-2 clinical trial show that the novel drug GC4419 may be promising in treating patients with unresectable or borderline resectable locally advanced pancreatic cancer […]

By Ellen Zimmerman The Therapeutics-Focused Research Program will advance the understanding of the causes and progression of pancreatic cancer and will identify new potential therapies. This grant program will stimulate […]

New combination of three existing immunotherapy drugs may eliminate pancreatic tumors By Stephanie Elsea When it comes to fighting and destroying infected or diseased cells, T cells are the heroes. The body’s front line of defense, T cells are like soldiers deployed at […]

A new study from Queen Mary University of London has demonstrated that immune cells can be stimulated to assemble into special structures within pancreatic cancer such that, at least in […]

A diagnostic tool called the MasSpec Pen has been tested for the first time in pancreatic cancer patients during surgery. The device is shown to accurately identify tissues and surgical […]